Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication

NCT00783081 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

Intermittent Claudication

Interventions

DRUG: K-134
DRUG: Cilostazol 100 mg BID
DRUG: Placebo

Sponsor

Kowa Research Institute, Inc.